CF
FLNA

Corebridge Financial’s Filana Therapeutics FLNA Stock Holding History

Corebridge Financial’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19,896
Closed -$29.8K – 2276
2025
Q1 		$29.8K Sell
19,896
-295
-1% -$744 ﹤0.01% 2842
2024
Q4 		$47.7K Sell
20,191
-1,524
-7% -$26.8K ﹤0.01% 2844
2024
Q3 		$639K Sell
21,715
-134
-0.6% -$3.09K ﹤0.01% 1598
2024
Q2 		$270K Buy
+21,849
New +$461K ﹤0.01% 2017

Other funds holding FLNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Corebridge Financial's FLNA Position: Q2 2025 in Review

Corebridge Financial sold out of Filana Therapeutics (FLNA) in Q2 2025, closing a stake of 19,896 shares — an estimated $29.8K sold.

Corebridge Financial first reported a position in FLNA in Q2 2024 and held it in 4 quarters. The position peaked at $639K in Q3 2024. 97 funds tracked by Wall St. Rank hold FLNA as of Q2 2025.

  • Corebridge Financial reported no remaining Filana Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 19,896 Filana Therapeutics shares in Q2 2025, an estimated $29.8K.
  • Corebridge Financial first reported a position in Filana Therapeutics in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Filana Therapeutics position peaked at $639K in Q3 2024.
  • 97 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.